| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALDER BIOPHARMACEUTICALS INC | 1,278,570 | 31,312,000 | 24.23% | ||
| 2 | WAVE LIFE SCIENCES LTD | 1,411,749 | 17,855,000 | 13.81% | ||
| 3 | AERIE PHARMACEUTICALS INC | 957,126 | 11,639,000 | 9.01% | ||
| 4 | GLOBAL BLOOD THERAPEUTICS IN COM | 497,000 | 7,882,000 | 6.10% | ||
| 5 | ZAFGEN INC COM | 1,050,837 | 7,020,000 | 5.43% | ||
| 6 | EPIZYME INC COM | 476,777 | 5,779,000 | 4.47% | ||
| 7 | REGULUS THERAPEUTICS INC | 789,091 | 5,468,000 | 4.23% | ||
| 8 | ARDELYX INC COM | 648,340 | 5,038,000 | 3.90% | ||
| 9 | AIMMUNE THERAPEUTICS INC COM | 355,020 | 4,814,000 | 3.72% | ||
| 10 | AVEXIS INC COM | 168,195 | 4,582,000 | 3.55% | ||
| 11 | NEURODERM LTD | 292,371 | 4,128,000 | 3.19% | ||
| 12 | LIPOCINE INC NEW | 397,107 | 4,031,000 | 3.12% | ||
| 13 | AKARI THERAPEUTICS PLC | 263,921 | 3,695,000 | 2.86% | ||
| 14 | SANGAMO BIOSCIENCES INCORPORATED | 544,816 | 3,296,000 | 2.55% | ||
| 15 | Intersect ENT Inc | 168,550 | 3,202,000 | 2.48% | ||
| 16 | ACCELERON PHARMA | 94,403 | 2,491,000 | 1.93% | ||
| 17 | BELLICUM PHARMACEUTICALS INC COM | 205,990 | 1,926,000 | 1.49% | ||
| 18 | Orexigen Therapeutics, Inc. | 3,027,354 | 1,703,000 | 1.32% | ||
| 19 | REGENXBIO INC COM | 100,000 | 1,080,000 | 0.84% | ||
| 20 | DIMENSION THERAPEUTICS INC COM | 98,297 | 770,000 | 0.60% | ||
| 21 | BioDelivery Sciences International Inc | 207,498 | 670,000 | 0.52% | ||
| 22 | EDITAS MEDICINE INCORPORATED | 14,500 | 501,000 | 0.39% | ||
| 23 | IMMUNOGEN INCORPORATED | 42,815 | 365,000 | 0.28% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-099540, filed 2016.05.06).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
